2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate,
reboxetine,
reboxetine mesylate,
Vestra,
Reboxetine mesylate,
98769-84-7,
Reboxetine mesilate,
Edronax,
PNU 155950E,
71620-89-8,
FCE 20124,
Reboxetine mesylate [USAN],
(R)-2-((R)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine methanesulfonate,
Reboxetine mesylate (USAN),
DSSTox_CID_25690,
DSSTox_RID_81062,
DSSTox_GSID_45690,
93851-87-7,
Davedax,
(2R)-2-[(R)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine; methanesulfonic acid,
(2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; methanesulfonic acid,
105017-39-8,
CAS-98769-84-7,
Reboxetine (mesylate),
Reboxetine mesylate;,
Vestra (TN),
FCE20124 mesylate,
AC1L2RIX,
AC1Q6WCV,
NCGC00025335-01,
PNU155950E mesylate,
(+/-)-Reboxetine Mesylate,
( inverted exclamation markA)-(2r*)-2-[(ar*)-a-(o-ethoxyphenoxy)benzyl]morpholine methanesulfonate,
SCHEMBL260136,
C20H27NO6S,
(2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine;methanesulfonic acid,
(2R)-rel-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine Methanesulfonate,
CHEMBL2105282,
DTXSID8045690,
CTK8G2917,
AOB2309,
BH007,
ACT10901,
PNU 155905E,
Tox21_110964,
CR0014,
FC0011,
MFCD02184016,
s3199,
AKOS015895146,
Tox21_110964_1,
API0004733,
M20R898,
NCGC00263541-01,
AN-15040,
AS-15081,
LS-93006,
N926,
AB0016142,
AX8001268,
AX8327214,
FT-0653731,
SW219318-1,
A11919,
D02573,
A845908,
I06-1282,
Reboxetine Mesilate 1.0 mg/ml in Methanol (as free base),
UNII-L94J81YNNY component CGTZMJIMMUNLQD-STYNFMPRSA-N,
(2R)-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine mesylate,
(R*)-2-((R*)-(2-Ethoxyphenoxy)(phenyl)methyl)morpholine mesylate,
98769-84-7,71620-89-8(freebase),105017-40-1(HCl),
(+-)-(R*,S*)-2-((2-Ethoxyphenoxy)phenylmethyl)morpholine methanesulfonate,
(+-)-(2R*)-2-((alphaS*)-alpha-(o-Ethoxyphenoxy)benzyl)morpholine methanesulfonate,
Morpholine, 2-((2-ethoxyphenoxy)phenylmethyl)-, (R*,R*)-(+-)-, methanesulfonate,
Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-rel-, methanesulfonate,
Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-,methanesulfonate,
Reboxetine,
Reboxitine,
Vestra,
UNII-L94J81YNNY,
Reboxetine [INN:BAN],
(R,R)-reboxetine (mesylate),
L94J81YNNY,
UNII-947S0YZ36I,
C19H23NO3.CH4O3S,
HSDB 7701,
KST-1A0218,
PNU-155950E,
AR-1A0202,
CID127150,
ACN-048277,
C19-H23-N-O3.C-H4-O3-S,
B2124,
2-((2-Ethoxyphenoxy)phenylmethyl)morpholine methanesulfonate,
2-((2-Ethoxyphenoxy)(phenyl)methyl)morpholine methanesulfonate,
Morpholine, 2-((2-ethoxyphenoxy)phenylmethyl)-, methanesulfonate,
6284-04-4,
Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-, methanesulfonate (1:1),
141425-90-3,
98769-82-5,